Article
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
Emerging infectious diseases - 1 Oct 2004
Stein Cheryl R, Poole Charles, Kazanjian Powel, Meshnick Steven R
Abstract excerpt
A systematic review was conducted to examine the associations in Pneumocystis jirovecii pneumonia (PCP) patients between dihydropteroate synthase (DHPS) mutations and sulfa or sulfone (sulfa) prophylaxis and between DHPS mutations and sulfa treatment outcome. Selection criteria included study populations composed entirely of PCP patients and mutation or treatment outcome results for all patients, regardless of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
